bio:cap 2027

bio:cap is Messe Berlin's Life Science and AI Investival, a two-day event that pairs the depth of an investor conference with the atmosphere of a festival. Its mission is to connect breakthrough European research in biotech, TechBio, diagnostics and AI with the capital that turns it into companies, bringing start-ups and scale-ups together with international investors, pharma and industry leaders, research institutions and policymakers at CityCube Berlin.

Matchmaking and pitching

Curated, pre-booked 1:1 meetings link founders with investors and industry partners through the bio:cap app, and a dedicated pitch stage gives start-ups the spotlight to present their innovations and raise funding.

• Partnering Zone for pre-booked 1:1s
• Capital Zone for VCs, CVCs, family offices and private equity
• Startup Area and Scientific Area
• Pitch stage for founders

Content

Three main stages host keynotes from industry visionaries, global pharma leaders and policymakers, plus deep-dive sessions and panels on regulation and future strategy that bring innovators and government representatives together.

Networking, Berlin-style

Between sessions, attendees meet at the Tower & Plaza social hub, thematic Cafés, the Molecular Bar and a Berlin-style Späti with free snacks and drinks. The second evening ends with the bio:cap INVESTIVAL PARTY in a Berlin club, alongside citywide side events.

Who attends

Founders of start-ups and scale-ups, venture and corporate investors, pharma and industry decision-makers, research and clinical institutions, and policymakers working on life sciences and AI in Europe.